The bill would let the President negotiate trade agreements with countries to reduce or remove duties and other import restrictions on medical goods. Agreements could also cover supplier diversity, research, manufacturing, regulatory cooperation, government purchasing, and intellectual property protections. The bill requires reports and consultations with Congress, gives Congress time to review proposed agreements, and allows a joint resolution to block an agreement. It also requires monitoring of partners’ compliance and allows action if a partner does not meet its commitments.
The bill could change trade rules for medical devices, drugs, and related inputs between the United States and partner countries. It does not itself establish a specific agreement or guarantee changes to the supply or price of medical goods.
No publicly available information.
The bill states that its purpose is to strengthen medical supply chains, expand and diversify suppliers, and support reliable access to medical goods, including during public health emergencies.
No publicly available information.